Solventum Co. (NYSE:SOLV) Shares Acquired by Harbor Capital Advisors Inc.

Harbor Capital Advisors Inc. increased its position in shares of Solventum Co. (NYSE:SOLV) by 24.8% during the 4th quarter, Holdings Channel.com reports. The fund owned 46,965 shares of the company’s stock after acquiring an additional 9,333 shares during the period. Harbor Capital Advisors Inc.’s holdings in Solventum were worth $3,103,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of SOLV. MML Investors Services LLC lifted its position in shares of Solventum by 3.2% during the third quarter. MML Investors Services LLC now owns 5,345 shares of the company’s stock worth $373,000 after purchasing an additional 168 shares in the last quarter. Tokio Marine Asset Management Co. Ltd. lifted its holdings in Solventum by 4.2% during the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 4,966 shares of the company’s stock worth $346,000 after buying an additional 200 shares in the last quarter. National Bank of Canada FI boosted its position in Solventum by 4.0% in the 2nd quarter. National Bank of Canada FI now owns 6,093 shares of the company’s stock valued at $314,000 after buying an additional 236 shares during the period. IVC Wealth Advisors LLC grew its stake in shares of Solventum by 5.0% in the third quarter. IVC Wealth Advisors LLC now owns 6,649 shares of the company’s stock worth $464,000 after acquiring an additional 318 shares in the last quarter. Finally, KKM Financial LLC increased its position in shares of Solventum by 7.9% during the third quarter. KKM Financial LLC now owns 4,367 shares of the company’s stock worth $304,000 after acquiring an additional 319 shares during the period.

Solventum Trading Down 2.6 %

Shares of NYSE:SOLV opened at $67.19 on Friday. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15. The firm has a 50 day simple moving average of $69.32 and a 200-day simple moving average of $64.80. Solventum Co. has a twelve month low of $47.16 and a twelve month high of $96.05.

Analyst Ratings Changes

Several research analysts recently commented on SOLV shares. Mizuho started coverage on Solventum in a research note on Wednesday, December 4th. They set a “neutral” rating and a $70.00 target price for the company. Piper Sandler boosted their price objective on Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research report on Friday, November 8th. Wolfe Research began coverage on shares of Solventum in a report on Thursday, September 26th. They issued a “peer perform” rating on the stock. Morgan Stanley boosted their price target on shares of Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a report on Monday, November 11th. Finally, Stifel Nicolaus assumed coverage on shares of Solventum in a report on Tuesday, October 8th. They issued a “buy” rating and a $82.00 price objective on the stock. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $68.29.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.